Kyverna Therapeutics had a nice pop today and is currently up 5.86% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.
The company isn't at an immediate support or resistance level that might be predictive. KYTX hasn't established a very clear directional momentum over the last few months. So it's not clear exactly where it's going. KYTX may hit some resistance around the 7.47 level, more sellers may enter the market here and push price back down. But it's definitely not guaranteed.
